Bayer HealthCare LLC Sustainability Profile
Bayer HealthCare LLC, a prominent subsidiary of Bayer AG, is headquartered in the United States and operates extensively across North America and beyond. Founded in 1863, the company has established itself as a leader in the pharmaceutical and life sciences industry, focusing on areas such as prescription medications, consumer health products, and animal health solutions. Bayer HealthCare is renowned for its innovative core products, including advanced therapies in oncology, cardiology, and women's health, which are distinguished by their commitment to research and development. The company has achieved significant milestones, including numerous FDA approvals and recognitions for its contributions to healthcare. With a strong market position, Bayer HealthCare continues to make strides in improving patient outcomes and enhancing quality of life, solidifying its reputation as a trusted name in health and wellness.
DitchCarbon Score
How does Bayer HealthCare LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bayer HealthCare LLC's score of 87 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bayer HealthCare LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. However, the company is part of a broader corporate family under Bayer Aktiengesellschaft, which provides emissions data and climate commitments that are relevant to Bayer HealthCare's sustainability efforts. Bayer Aktiengesellschaft has set ambitious climate targets, including commitments to reduce greenhouse gas emissions across its operations. These targets are cascaded down to Bayer HealthCare LLC, reflecting the company's dedication to addressing climate change. The initiatives include participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the Climate Pledge, all of which aim to enhance transparency and accountability in emissions reduction. While specific reduction targets for Bayer HealthCare LLC are not detailed, the overarching goals from Bayer Aktiengesellschaft indicate a strong commitment to sustainability and reducing carbon footprints across all scopes of emissions. This includes Scope 1, 2, and 3 emissions, which encompass direct emissions from owned or controlled sources, indirect emissions from the generation of purchased energy, and all other indirect emissions that occur in a company’s value chain. In summary, while Bayer HealthCare LLC does not report specific emissions data, it is aligned with the climate commitments and reduction initiatives of its parent company, Bayer Aktiengesellschaft, demonstrating a proactive approach to environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | - | 0,000,000,000 | 0,000,000,000 | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 1,215 | 0,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Bayer HealthCare LLC's Industry?
How Carbon Intensive is Bayer HealthCare LLC's Location?
Bayer HealthCare LLC's Scope 3 Categories Breakdown
Bayer HealthCare LLC's Scope 3 emissions, which decreased by 16% last year and increased significantly since 2004, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 72% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 76% of Scope 3 emissions.
Top Scope 3 Categories
Bayer HealthCare LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bayer HealthCare LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
